Sherril S Haselden

Title: Sherril S Haselden: Innovator in Hematological Treatments

Introduction

Sherril S Haselden is a prominent inventor based in Santa Cruz, CA (US). She has made significant contributions to the field of hematology through her innovative research and development of peptides and compounds. With a total of 4 patents, Haselden's work focuses on addressing critical medical conditions.

Latest Patents

Haselden's latest patents include groundbreaking work on peptides and peptide mimetics that bind to and activate the thrombopoietin receptor. These innovations are particularly useful in treating hematological disorders, especially thrombocytopenia resulting from chemotherapy, radiation therapy, or bone marrow transfusions. Additionally, her research includes diagnostic methods that employ labeled peptides and peptide mimetics, further enhancing the potential for medical advancements in this area.

Career Highlights

Throughout her career, Haselden has worked with notable companies such as SmithKline Beecham Corporation and Glaxo Wellcome Inc. Her experience in these organizations has contributed to her expertise and success in the field of biomedical research.

Collaborations

Haselden has collaborated with esteemed colleagues, including William J Dower and Ronald W Barrett. These partnerships have fostered a collaborative environment that has led to significant advancements in her research.

Conclusion

Sherril S Haselden's contributions to the field of hematology through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for new treatments and diagnostic methods in the medical community.